SE9902269D0 - Pharmaceutically active compounds - Google Patents

Pharmaceutically active compounds

Info

Publication number
SE9902269D0
SE9902269D0 SE9902269A SE9902269A SE9902269D0 SE 9902269 D0 SE9902269 D0 SE 9902269D0 SE 9902269 A SE9902269 A SE 9902269A SE 9902269 A SE9902269 A SE 9902269A SE 9902269 D0 SE9902269 D0 SE 9902269D0
Authority
SE
Sweden
Prior art keywords
active compounds
pharmaceutically active
arrhythmias
prophylaxis
useful
Prior art date
Application number
SE9902269A
Other languages
English (en)
Swedish (sv)
Inventor
Magnus Bjoersne
Marianne Frantsi
Kurt-Juergen Hoffmann
Bengt Olsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9902269A priority Critical patent/SE9902269D0/xx
Publication of SE9902269D0 publication Critical patent/SE9902269D0/xx
Priority to BR0011667-0A priority patent/BR0011667A/pt
Priority to ES00946588T priority patent/ES2214291T3/es
Priority to AU60323/00A priority patent/AU762040B2/en
Priority to HU0300244A priority patent/HUP0300244A3/hu
Priority to CNB008116075A priority patent/CN1187351C/zh
Priority to KR1020017016167A priority patent/KR20020042534A/ko
Priority to EEP200100679A priority patent/EE200100679A/xx
Priority to CA002377395A priority patent/CA2377395A1/en
Priority to PCT/SE2000/001252 priority patent/WO2000076998A1/en
Priority to TR2001/03635T priority patent/TR200103635T2/xx
Priority to EP00946588A priority patent/EP1192156B1/en
Priority to PL00353155A priority patent/PL353155A1/xx
Priority to NZ516014A priority patent/NZ516014A/xx
Priority to DE60008377T priority patent/DE60008377T2/de
Priority to CZ20014493A priority patent/CZ20014493A3/cs
Priority to IL14675100A priority patent/IL146751A0/xx
Priority to PT00946588T priority patent/PT1192156E/pt
Priority to DK00946588T priority patent/DK1192156T3/da
Priority to AT00946588T priority patent/ATE259809T1/de
Priority to MXPA01012926A priority patent/MXPA01012926A/es
Priority to JP2001503856A priority patent/JP2003502327A/ja
Priority to SK1829-2001A priority patent/SK18292001A3/sk
Priority to ARP000103016A priority patent/AR024392A1/es
Priority to IS6200A priority patent/IS6200A/is
Priority to ZA200109798A priority patent/ZA200109798B/en
Priority to NO20016120A priority patent/NO20016120L/no
Priority to HK02107114.4A priority patent/HK1045689A1/zh
Priority to US10/831,369 priority patent/US20050004113A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE9902269A 1999-06-16 1999-06-16 Pharmaceutically active compounds SE9902269D0 (sv)

Priority Applications (29)

Application Number Priority Date Filing Date Title
SE9902269A SE9902269D0 (sv) 1999-06-16 1999-06-16 Pharmaceutically active compounds
SK1829-2001A SK18292001A3 (sk) 1999-06-16 2000-06-15 Bispidínové zlúčeniny užitočné pri liečbe srdcových arytmií
PL00353155A PL353155A1 (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias
DE60008377T DE60008377T2 (de) 1999-06-16 2000-06-15 Bispidin-derivate zur behandlung von herzarrhythmien
AU60323/00A AU762040B2 (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias
HU0300244A HUP0300244A3 (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation, pharmaceutical compositions containing them and their use
CNB008116075A CN1187351C (zh) 1999-06-16 2000-06-15 桥合二哌啶化合物及其用途，制备方法和中间体以及含有这些化合物的药物组合物
KR1020017016167A KR20020042534A (ko) 1999-06-16 2000-06-15 심부정맥의 치료에 유용한 신규 비스피딘 화합물
EEP200100679A EE200100679A (et) 1999-06-16 2000-06-15 Bispidiini uued arütmiavastased ühendid, mida kasutatakse südame arütmia ravis
CA002377395A CA2377395A1 (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias
PCT/SE2000/001252 WO2000076998A1 (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias
TR2001/03635T TR200103635T2 (tr) 1999-06-16 2000-06-15 Kardiyak aritmaların tedavisinde faydalı yeni bispidin bileşikleri.
EP00946588A EP1192156B1 (en) 1999-06-16 2000-06-15 Bispidine compounds useful in the treatment of cardiac arrhythmias
BR0011667-0A BR0011667A (pt) 1999-06-16 2000-06-15 Composto, formulação farmaceutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo de preparação de um composto
NZ516014A NZ516014A (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias
ES00946588T ES2214291T3 (es) 1999-06-16 2000-06-15 Compuestos de bispidina utiles en el tratamiento de arritmias cardiacas.
CZ20014493A CZ20014493A3 (cs) 1999-06-16 2000-06-15 Nové bispidinové sloučeniny vhodné k léčení srdeční arytmie
IL14675100A IL146751A0 (en) 1999-06-16 2000-06-15 New bispidine compounds useful in the treatment of cardiac arrhythmias
PT00946588T PT1192156E (pt) 1999-06-16 2000-06-15 Novos compostos de bispidina uteis no tratamento de arritmias cardiacas
DK00946588T DK1192156T3 (da) 1999-06-16 2000-06-15 Bispidinforbindelser, som er egnede til behandling af hjertearytmier
AT00946588T ATE259809T1 (de) 1999-06-16 2000-06-15 Bispidin-derivate zur behandlung von herzarrhythmien
MXPA01012926A MXPA01012926A (es) 1999-06-16 2000-06-15 Nuevos compuestos de bispidina utiles en el tratamiento de las arritmias cardiacas.
JP2001503856A JP2003502327A (ja) 1999-06-16 2000-06-15 心臓不整脈の治療に有用な新規ビスピジン化合物
ARP000103016A AR024392A1 (es) 1999-06-16 2000-06-16 Nuevos compuestos de bispidina utiles en el tratamiento de arritmias cardiacas.
IS6200A IS6200A (is) 1999-06-16 2000-12-14 Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
ZA200109798A ZA200109798B (en) 1999-06-16 2001-11-28 New bispidine compounds useful in the treatment of cardiac arrhythmias.
NO20016120A NO20016120L (no) 1999-06-16 2001-12-14 Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier
HK02107114.4A HK1045689A1 (zh) 1999-06-16 2002-09-26 用於治療心臟心律不齊的雙哌啶類化合物
US10/831,369 US20050004113A1 (en) 1999-06-16 2004-04-26 New bispidine compounds useful in the treatment of cardiac arrhythmias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902269A SE9902269D0 (sv) 1999-06-16 1999-06-16 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
SE9902269D0 true SE9902269D0 (sv) 1999-06-16

Family

ID=20416101

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902269A SE9902269D0 (sv) 1999-06-16 1999-06-16 Pharmaceutically active compounds

Country Status (28)

Country Link
EP (1) EP1192156B1 (hu)
JP (1) JP2003502327A (hu)
KR (1) KR20020042534A (hu)
CN (1) CN1187351C (hu)
AR (1) AR024392A1 (hu)
AT (1) ATE259809T1 (hu)
AU (1) AU762040B2 (hu)
BR (1) BR0011667A (hu)
CA (1) CA2377395A1 (hu)
CZ (1) CZ20014493A3 (hu)
DE (1) DE60008377T2 (hu)
DK (1) DK1192156T3 (hu)
EE (1) EE200100679A (hu)
ES (1) ES2214291T3 (hu)
HK (1) HK1045689A1 (hu)
HU (1) HUP0300244A3 (hu)
IL (1) IL146751A0 (hu)
IS (1) IS6200A (hu)
MX (1) MXPA01012926A (hu)
NO (1) NO20016120L (hu)
NZ (1) NZ516014A (hu)
PL (1) PL353155A1 (hu)
PT (1) PT1192156E (hu)
SE (1) SE9902269D0 (hu)
SK (1) SK18292001A3 (hu)
TR (1) TR200103635T2 (hu)
WO (1) WO2000076998A1 (hu)
ZA (1) ZA200109798B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030302A1 (es) * 2000-07-07 2003-08-20 Astrazeneca Ab Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US5468858A (en) * 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
JP2003502327A (ja) 2003-01-21
PT1192156E (pt) 2004-06-30
IL146751A0 (en) 2002-07-25
AU6032300A (en) 2001-01-02
EE200100679A (et) 2003-02-17
CN1370165A (zh) 2002-09-18
DK1192156T3 (da) 2004-05-17
ES2214291T3 (es) 2004-09-16
DE60008377T2 (de) 2004-12-09
DE60008377D1 (de) 2004-03-25
SK18292001A3 (sk) 2002-12-03
ATE259809T1 (de) 2004-03-15
KR20020042534A (ko) 2002-06-05
HK1045689A1 (zh) 2002-12-06
AU762040B2 (en) 2003-06-19
NO20016120D0 (no) 2001-12-14
NZ516014A (en) 2003-06-30
IS6200A (is) 2001-12-14
WO2000076998B1 (en) 2001-03-08
BR0011667A (pt) 2002-04-02
MXPA01012926A (es) 2002-07-30
CA2377395A1 (en) 2000-12-21
NO20016120L (no) 2002-02-18
EP1192156B1 (en) 2004-02-18
ZA200109798B (en) 2003-02-28
HUP0300244A3 (en) 2003-12-29
WO2000076998A1 (en) 2000-12-21
PL353155A1 (en) 2003-10-20
CN1187351C (zh) 2005-02-02
HUP0300244A2 (hu) 2003-06-28
EP1192156A1 (en) 2002-04-03
AR024392A1 (es) 2002-10-02
TR200103635T2 (tr) 2002-04-22
CZ20014493A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
SE9704709D0 (sv) Pharmaceutically active compounds
WO2001028992A3 (en) New oxabispidine compounds useful in the treatment of cardiac arrhythmias
AU1497692A (en) Sulfonamides and their medical use
CA2260337A1 (en) Therapeutic agents
CY1106178T1 (el) 2’- υποκατεστημενα 1,1’-διφαινυλο-2-καρβοξαμιδια, μεθοδος για την παρασκευη τους, η χρηση τους ως φαρμακου καθως και φαρμακευτικα παρασκευασματα που τα πepιεχουν
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
NO20012000L (no) N-(2-aryl-propionyl)-sulfonamider og farmasöytiske prepareringer som inneholder dem
AU3850600A (en) Dalda analogs and their use
SE0004245D0 (sv) Novel compounds and their use
SE0100326D0 (sv) New compounds
AU2001266575A1 (en) Chemical compounds
SE9904765D0 (sv) Pharmaceutically-useful compounds
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
SE0003795D0 (sv) Pharmaceutically useful compounds
CA2309474A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
ATE263160T1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
DK1204659T3 (da) Serotonerge benzofuraner
WO2003024941A1 (fr) Composes de naphtalene et leur utilisation comme medicament
SE9902268D0 (sv) Pharmaceutically active compounds
SE9902270D0 (sv) Pharmaceutically active compounds
SE9902269D0 (sv) Pharmaceutically active compounds
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
SE9902271D0 (sv) Pharmaceutically active compounds
SE0002603D0 (sv) New compounds